Third CISCE Reflects China’s Role in Strengthening Supply Chain Integration, Innovation, and Resilience
BEIJING, July 21, 2025 /PRNewswire/ — “The Chinese supply chain is a miracle. The Chinese market is vast and full of vitality.” These were the remarks of NVIDIA Chief Executive Officer Jensen Huang during an interview at the third China International Supply Chain Expo (CISCE, the Expo).
Held in Beijing from July 16th to 20th, the third CISCE served as a key platform for facilitating international cooperation in the supply chain sector. The event’s 6 Chains + 1 Exhibition Area structure underscored the importance of enhancing integration and innovation across industrial ecosystems.
The Expo offers a comprehensive view of the adaptability and innovative capacity of China’s supply chains, reinforcing their position as a central link in global economic connectivity and long-term development.
“Over 80 percent of Apple’s 200 major global suppliers manufacture in China,” Tim Cook, Apple Chief Executive Officer, noted during his visit at the second CISCE.
As the first national-level exposition dedicated exclusively to supply chains, CISCE has emerged as a platform for both policy dialogue and industry engagement, where more insightful trends on dynamic global supply chains could be found at https://en.cisce.org.cn/.
Video – https://mma.prnewswire.com/media/2734862/4K_0716_150mb.mp4
Logo – https://mma.prnewswire.com/media/2427202/CISCE_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/china-international-supply-chain-expo-highlights-global-collaboration-302509422.html
Dubai, UAE, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a new crypto coin…
Not for distribution to U.S. news wire services or dissemination in the United States December…
December 12, 2025 18:39 ET | Source: TransAlta Corporation CALGARY, Alberta, Dec. 12, 2025 (GLOBE…
Global fans to experience the Games of the Future like never before as MOBA PC.Dota 2 competition…
HONG KONG, Dec. 12, 2025 /PRNewswire/ -- TutorABC Group, one of the world's most established…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel…